Clustering data with hclust algorithm for Metabolomics of intensive weight management clinic (IWMC) weight loss (Study ST000744)

Reversed phase POSITIVE ION MODE (Analysis AN001163)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10
3-(4-HYDROXYPHENYL)LACTIC ACID (M+H)+ME2063280.88NA0.590.25NA1.421.59NA1.180.98
1-METHYLXANTHINE (M+H)+ME2063190.870.951.011.001.011.080.931.041.001.07
5^-METHYLTHIOADENOSINE (M+H)+ME2063350.961.011.101.160.870.940.860.731.121.10
4-PYRIDOXIC ACID (M+NA)+ME2063330.521.530.810.500.460.350.731.230.623.87
ADENOSINE 5^-MONOPHOSPHATE (M+H)+ME2063380.920.910.940.690.701.710.461.481.112.00
2-HYDROXY-3-METHYLBUTYRIC ACID (M+NA)+ME2063251.020.931.050.791.240.920.641.021.251.21
1-METHYLXANTHINE (M+NA)+ME2063200.931.070.900.651.091.271.021.151.091.18
25-HYDROXYCHOLESTEROL (M+H)+[-H2O]ME2063271.301.770.860.991.400.941.060.410.840.58
3-METHYLXANTHINE (M+H)+ME2063320.870.961.011.001.021.060.941.031.001.07
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+ME2063170.950.901.071.061.061.310.511.310.620.89
3-DEHYDROSHIKIMIC ACID (M+H)+[-H2O]ME2063291.450.901.000.910.950.731.180.831.320.98
18:0 LYSO-PE (M+H)+ME2063241.261.191.230.890.840.850.770.910.801.32
ACETYLCARNITINE (M+H)+ME2063360.810.520.870.760.830.800.490.831.722.85
3-METHOXYTYROSINE (M+H)+ME2063311.190.891.321.070.661.050.940.491.270.83
4-QUINOLINECARBOXYLIC ACID #2 (M+H)+ME2063340.651.230.910.890.781.250.631.021.731.16
16:0 LYSO PC (M+NA)+ME2063221.030.941.030.861.010.960.761.381.151.03
16:0-18:0 PC (M+H)+ME2063230.920.870.871.041.160.931.171.190.910.99
16:0 LYSO PC (M+H)+ME2063210.880.960.991.061.051.000.980.891.001.10
1-METHYLADENOSINE (M+H)+ME2063180.920.971.050.980.841.080.960.941.161.10
3-HYDROXYBENZALDEHYDE (M+H)+[-H2O]ME2063301.050.641.681.770.450.410.510.900.720.99

Factors:

F1Gender:female | Glycemic status:Diabetic | Neuropathy:Neuropathy
F2Gender:female | Glycemic status:Diabetic | Neuropathy:no neuropathy
F3Gender:female | Glycemic status:Pre-diabetic | Neuropathy:Neuropathy
F4Gender:female | Glycemic status:Pre-diabetic | Neuropathy:no neuropathy
F5Gender:male | Glycemic status:Diabetic | Neuropathy:Neuropathy
F6Gender:male | Glycemic status:Diabetic | Neuropathy:no neuropathy
F7Gender:male | Glycemic status:Normoglycemic | Neuropathy:Neuropathy
F8Gender:male | Glycemic status:Normoglycemic | Neuropathy:no neuropathy
F9Gender:male | Glycemic status:Pre-diabetic | Neuropathy:Neuropathy
F10Gender:male | Glycemic status:Pre-diabetic | Neuropathy:no neuropathy
Data matrix
  logo